Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × aflibercept × Dermatologic × Clear all

Phase

Phase 2 4 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Thoracic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Uveal Melanoma 1

Interventions

Dacarbazine 24 Nivolumab 21 pembrolizumab 18 Ipilimumab 16 3-ingenyl angelate 11 Interferon-alpha 10 Imiquimod 10 trametinib 8 Temozolomide 8 dabrafenib 7 aldesleukin 7 Vemurafenib 7 Photochemotherapy 7 methyl 5-aminolevulinate 6 cemiplimab 6 Radiotherapy 6 Introns 6 Interferon alpha-2 6 Fluorouracil 6 Aminolevulinic Acid 6 Surgical Procedures, Operative 5 Melphalan 5 Interleukin-2 5 Cisplatin 5 binimetinib 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Gels 4 Diclofenac 4 Chemotherapy, Adjuvant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03172299 2025-03-24

PROTECT

Centre Hospitalier Universitaire de Nice

Phase 3 Completed

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡